Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342445 · ClinicalTrials.gov registry record · Phase 4
Effects of LDX on Functioning of College Students With ADHD
A Phase 4 study, sponsored by University of Rhode Island.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT01342445 is a Phase 4 study that has completed, run by University of Rhode Island. The registered enrollment target is 50 participants.
The verdict
NCT01342445, a Phase 4 study, has completed, sponsored by University of Rhode Island.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the effects of lisdexamfetamine dimesylate, a prodrug stimulant, on the behavioral, academic, and psychosocial functioning of college students with attention-deficit/hyperactivity disorder (ADHD). Twenty-five college students with ADHD from two universities (University of Rhode Island and Lehigh University) completed a within-subject, placebo-controlled research trial. Dependent measures tapping behavioral, psychosocial, and academic functioning were completed on a weekly basis across five conditions (baseline, placebo, and 30-mg, 50-mg, and 70-mg lisdexamfetamine).
Interventions
- DRUG Placebo
- DRUG lisdexamfetamine dimesylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01342445
The ClinicalTrials.gov registry entry for NCT01342445 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rhode Island, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01342445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01342445 about?
NCT01342445 is a clinical study titled "Effects of LDX on Functioning of College Students With ADHD". The purpose of this study was to evaluate the effects of lisdexamfetamine dimesylate, a prodrug stimulant, on the behavioral, academic, and psychosocial functioning of college students with attention-deficit/hyperactivity disorder (ADHD). Twenty-five college students with ADHD from two universities ...
What is the current status of trial NCT01342445?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2009-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01342445?
The interventions under investigation include: Placebo (DRUG), lisdexamfetamine dimesylate (DRUG).
Who is sponsoring clinical trial NCT01342445?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.